Purchase Order 75N93021P00889

This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Seattle Children's Hospital, a non-profit healthcare provider, to conduct a longitudinal study on COVID-19 antibody response in children in Seattle, Washington. The $2,304,624 definitive contract, awarded on June 12, 2020, does not have a set-aside designation and is scheduled for completion by January 31, 2024. As the prime contractor, Seattle Children's Hospital has subcontracted with the Fred...

The Johns Hopkins University (JHU) was awarded a definitive cost-no-fee contract valued at $3.51 million by the Centers for Disease Control and Prevention (CDC) to conduct the JHU COVID-19 Pediatric Study. The study will be performed over 14 months in Baltimore, Maryland and aims to advance the CDC's understanding of coronavirus disease 2019 (COVID-19) transmission and severity among children. Major subcontractors include Abt Associates Inc. to develop and administer a study database and provide...

This is a $24,899,418.92 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract is for a COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Vaccine Effectiveness (VE) study, with a period of performance ending on September 15, 2026. The contract does not have a set-aside...

This is a $5,092,787.07 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract is for COVID-19 research focused on critically ill children and does not have a set-aside designation. Boston Children's Hospital is a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical School. Through this contract, the hospital is...

This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital of Philadelphia (CHOP) on July 1, 2020. The contract, valued at $449,879.00, is for a project titled "PERINATAL COVID-19 IN THE UNITED STATES: SURVEILLANCE AND EPIDEMIOLOGY" with a completion date of September 30, 2022. The contract does not have a set-aside designation. CHOP, a non-profit pediatric hospital and...

The Food and Drug Administration awarded a $87,181 firm fixed price purchase order to The Children's Hospital of Philadelphia (CHOP) on July 18, 2022, for a study on the natural history of enteroviral sepsis using real-world data. The contract, which carries no set-aside designation, is scheduled for completion by August 31, 2023, with performance taking place in Silver Spring, Maryland. This research initiative aligns with FDA's regulatory science mission and the agency's interest in...

This is a $6,157,849.35 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Children's Mercy Hospital, a non-profit pediatric medical center and research institution located in Kansas City, Missouri. The contract is for a Broad Agency Announcement (BAA) research effort focused on the epidemiology of symptomatic and asymptomatic respiratory viruses, as well as the evaluation of COVID-19 and influenza vaccine effectiveness in K-12 populations. The contract does...

This is a $11,787,024.00 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Children's Mercy Hospital in Kansas City, Missouri. The contract is for a project titled "IMPACT OF VENTILATION AND ENVIRONMENTAL INTERVENTIONS ON RESPIRATORY VIRAL TRANSMISSION IN K-12 SCHOOLS" and has an ultimate completion date of August 31, 2027. The contract does not have a set-aside designation. Through this contract, Children's Mercy Hospital will...

This is a $19,543,164.01 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Rush University Medical Center. The contract is for a study titled "Innovative Support for Patients with SARS-CoV-2 Infections (INSPIRE) Registry" to determine the outcomes of SARS-CoV-2 infections among different age groups in the U.S. population. The contract was originally awarded on September 1, 2020 for an 18-month study with 4,800 participants. The CDC...

The Centers for Disease Control and Prevention, an agency of the Department of Health and Human Services, awarded a $9,990,604.91 firm fixed price definitive contract to Boston Children's Hospital for MIS-C in Children. As the prime contractor, Boston Children's Hospital will deliver services to investigate Multisystem Inflammatory Syndrome in Children (MIS-C), a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or...